Central Data Catalog
Citation Information
Type | Journal Article - Lancet Infect Dis |
Title | Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial |
Author(s) | |
Volume | 11 |
Publication (Day/Month/Year) | 2011 |
Page numbers | 741-749 |
URL | http://www.ncbi.nlm.nih.gov/pubmed/?term=Safety+and+efficacy+of+the+RTS%2CS%2FAS01%28E%29+candidate+malaria+vaccine+given+with+expanded-programme-on-immunisation+vaccines%3A+19+month+follow-up+of+a+randomised%2C+open-label%2C+phase+2+trial. http://www.ncb |
Asante, Kwaku Poku, Salim Abdulla, Selidji Agnandji, John Lyimo, Johan Vekemans, Solange Soulanoudjingar, Ruth Owusu, Mwanajaa Shomari, Amanda Leach, Erik Jongert, Nahya Salim, Jose F. Fernandes, David Dosoo, Maria Chikawe, Saadou Issifou, Kingsley Osei-Kwakye, Marc Lievens, Maria Paricek, Tina Möller, Stephen Apanga, Grace Mwangoka, Marie-Claude Dubois, Tigani Madi, Evans Kwara, Rose Minja, Aurore B. Hounkpatin, Owusu Boahen, Kingsley Kayan, George Adjei, Daniel Chandramohan, Terrell Carter, Preeti Vansadia, Marla Sillman, Barbara Savarese, Christian Loucq, Didier Lapierre, Brian Greenwood, Joe Cohen, Peter Kremsner, Seth Owusu-Agyei, Marcel Tanner, and Bertrand Lell. "Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial." Lancet Infect Dis (2011).